Moreover, high risk score indicated a higher IL2-STAT5 signaling score, IL6-JAK-STAT3 signaling score, NOTCH signaling score, P53 pathway score, and G2M checkpoint score in ovarian cancer (Figure 3G–3K, all p<0.05). This evidence concerns the gene TP53 and ovarian carcinoma.